Latest Stock Market News

​One word of caution here I may just want to give and specifically for the thematic plays that one would want to play because it is not right because when you construct a portfolio you talk about core allocation, you talk about strategic allocation and then the tactical bit.

Several BSE small cap stocks, such as Rico Auto Industries and KPR Mill, are moving closer to their 52-week highs, drawing the attention of market participants and investors. The companies have showcased strong operational capabilities and a positive outlook, making them intriguing prospects for future growth. Rico Auto Industries has expertise in manufacturing automotive components while KPR Mill specializes in the textile industry. Dynamatic Technologies, with a focus on precision engineering and aerospace solutions, has also demonstrated remarkable strength. The others nearing their 52-week highs are LG Balakrishnan & Bros, Ramkrishna Forgings, Power Mech Projects, and JBM Auto.

Stocks that have closed below their 200-day Simple Moving Average (SMA) can indicate a possible change in market sentiment and offer entry points for value investors. Companies such as Ambuja Cements, Whirlpool of India, and Coal India show potential long-term growth prospects despite closing below the 200-day SMA, while caution should be exercised when considering Vodafone Idea and Greenpanel Industries as investment options. Additional research and analysis of financials and industry trends are advised before making any investment decisions based on this trend.

The Bullish Harami Cross candlestick pattern has been spotted in the technical charts of several prominent stocks, indicating a possible trend reversal and presenting an opportunity for investors to explore. These include The Fertilisers And Chemicals Travancore, Kansai Nerolac Paints, Godrej Industries, Macrotech Developers, Jindal Stainless, and Natco Pharma. However, investors should conduct further research and analyze fundamental factors before making investment decisions. The Bullish Harami Cross pattern can serve as a valuable tool in identifying potential investment opportunities.

Nifty MNC stands out as one of the indices that have observed a double-digit surge in H1CY23

A total of 2,183,743 shares changed hands on the counter till 02:09PM (IST).

​However, I am not a big believer in China stimulus being able to push demand meaningfully because their problem for housing sector runs very deep.

Candlestick patterns of Kalyan Jewellers, Medplus Health Services, TV18 Broadcast, and Piramal Pharma, have been analyzed to shed light on potential investment opportunities. The Doji and Near Doji patterns have been discussed, which indicate market indecision and a potential reversal or trend continuation, based on context and preceding price action. These companies are leaders in jewelry, healthcare, media, and pharmaceutical industries, respectively. Investors are advised to conduct thorough research, stay informed on market trends, and consider various factors before making investment decisions.

Nifty Midcap100 stocks have made a significant recovery from their 52-week lows, attracting investors seeking potential opportunities. Tube Investments of India has recovered impressively from Rs 1,457.60 to Rs 3,000, showing its ability to bounce back. Apollo Tyres has rebounded to Rs 408.05 from its 52-week low of Rs 167.1, displaying market confidence in its growth prospects. Similarly, CG Power and Industrial Solutions, Indian Bank, Power Finance Corporation, Aditya Birla Capital, and BHEL all have experienced significant recoveries from their respective 52-week lows.

Jefferies has given a target of Rs 2,680 to JB Pharmaceuticals,respectively based on 20x June-25 EV-EBITDA valuations, due to its dominance in cardiac and gastro therapies and successful life cycle management of brands. The company has a 15% higher valuation than its peer, Torrent Pharma, due to superior financials. Alongside the strong brand position, JB exports to over 40 countries using innovative technology. Jefferies believes JB Pharma will emerge as one of the fastest-growing mid-sized companies with a 12/17%/20% growth in revenue/EBITDA/PAT CAGR over the next three years.